循環器ジャーナル69巻4号

2021年10月発行

特集 プレシジョン・メディシン時代における腫瘍循環器学の重要性 Ⅰ章　腫瘍循環器学とは

国内外における腫瘍循環器学の現状と今後の展望

著者： 南学¹

所属機関： ¹国立研究開発法人国立循環器病研究センターデータサイエンス部

ページ範囲：P.544 - P.549

Point
・腫瘍循環器学は新たな学際領域であるが，国内外でめざましい広がりを見せている．
・充実したがんサバイバーシップ実現に腫瘍循環器学は欠かすことができない．
・腫瘍循環器学は，循環器疾患の新規病態メカニズム解明の扉を開く可能性がある．

参考文献

1) Minami M, Matsumoto S, Horiuchi H:Cardiovascular side-effects of modern cancer therapy. Circ J 74:1779-1786, 2010

2) Cowgill JA, Francis SA, Sawyer DB:Anthracycline and Peripartum Cardiomyopathies-Predictably Unpredictable-. Circ Res 124:1633-1646, 2019

3) Armstrong GT, Oeffinger KC, Chen Y, et al:Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol 31:3673-3680, 2013

4) Armstrong GT, Kawashima T, Leisenring W, et al:Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218-1227, 2014

5) Khanna A, Pequeno P, Gupta S, et al:Increased Risk of All Cardiovascular Disease Subtypes Among Childhood Cancer Survivors-Population-Based Matched Cohort Study-. Circulation 140:1041-1043, 2019

6) Patnaik JL, Byers T, DiGuiseppi C, et al:Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer. Breast Cancer Res 13:R64, 2011

7) Yeh ET:Onco-cardiology:the time has come. Tex Heart Inst J 38:246-247, 2011

8) Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al;ESC Scientific Document Group:2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology（ESC）. Eur Heart J 37:2768-2801, 2016

9) Chang HM, Moudgil R, Scarabelli T, et al:Cardiovascular Complications of Cancer Therapy:Best Practices in Diagnosis, Prevention, and Management. J Am Coll Cardiol 70:2536-2565, 2017

10) Genovese G, Kähler AK, Handsaker RE, et al:Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371:2477-2487, 2014

11) Jaiswal S, Fontanillas P, Flannick J, et al:Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371:2488-2498, 2014

12) Saiki R, Momozawa Y, Nannya Y, et al:Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesis. Nat Med 27:1239-1249, 2021